Document Detail


Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
MedLine Citation:
PMID:  21943035     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Bayas A, Penzien J, Hellwig K. Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis. Acta Neurol Scand: 2011: 124: 290-292. © 2011 John Wiley & Sons A/S. Background:  Natalizumab is neither licensed for the use in adolescents nor during pregnancy. There are no reports of accidental natalizumab exposure during pregnancy continued as long as to the third trimester of pregnancy. Aims:  We report the outcome of pregnancy in a 17-year-old adolescent patient with multiple sclerosis (MS) treated with natalizumab from the age of 16, who was diagnosed to be pregnant in the 31st gestational week (gw) of pregnancy. To our knowledge, this report describes the first patient receiving natalizumab to the third trimester of pregnancy. Case report:  Because of high relapse activity, natalizumab treatment was administered in an adolescent patient with MS. Pregnancy was diagnosed in the 31st gw after 17 natalizumab infusions, seven of them accidentally during pregnancy. Results:  Pre- and postnatal development of the child was normal. Conclusions:  The case reported indicates that accidentally continued natalizumab treatment until few weeks before delivery may have no negative impact on the developing foetus.
Authors:
A Bayas; J Penzien; K Hellwig
Related Documents :
976205 - Thyroid testis inter-relationship in indian palm squirrel, funambulus pennanti wroughton.
2654905 - Solving the mystery of menstrual dysfunction.
20610605 - Approach to the patient with resistance to thyroid hormone and pregnancy.
7115045 - Hand function in osteoarthritis.
17587045 - Ectopic pregnancy in king fahad hofuf hospital: a five year experience.
824955 - Fetal lung lecithin metabolism and the amniotic fluid l/s ratio in rhesus monkey gestat...
Publication Detail:
Type:  Journal Article     Date:  2011-02-09
Journal Detail:
Title:  Acta neurologica Scandinavica     Volume:  124     ISSN:  1600-0404     ISO Abbreviation:  Acta Neurol. Scand.     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-09-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370336     Medline TA:  Acta Neurol Scand     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  290-2     Citation Subset:  IM    
Copyright Information:
© 2011 John Wiley & Sons A/S.
Affiliation:
Department of Neurology Klinikum Augsburg, Augsburg, Germany Pediatric Department, Klinikum Augsburg, Augsburg, Germany Department of Neurology, St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rapidly fatal neuropathies and an ALS clinical presentation.
Next Document:  Causes of death and demographic characteristics of victims of meteorological disasters in Korea from...